Protalix BioTherapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 143.7M |
| FY2018 | 14.8M |
| FY2019 | 14.8M |
| FY2020 | 29.1M |
| FY2021 | 44.1M |
| FY2022 | 48.5M |
| FY2023 | 82.4M |
| FY2024 | 81.1M |
| FY2025 | 78.5M |
| FY2026 | 80.6M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 143.7M |
| FY2018 | 14.8M |
| FY2019 | 14.8M |
| FY2020 | 29.1M |
| FY2021 | 44.1M |
| FY2022 | 48.5M |
| FY2023 | 82.4M |
| FY2024 | 81.1M |
| FY2025 | 78.5M |
| FY2026 | 80.6M |